--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About WVE20260515P5
Pharmaceutical
Wave Life Sciences Ltd., was incorporated in Singapore on July 23, 2012. The company is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA drugs (also known as oligonucleotides) or targeted ribonucleic acids (" RNA ") to transform human health. The company's RNA drug platform, PRISMTM, combines multiple models, chemical innovations and insights into human genetics to provide scientific breakthroughs in the treatment of rare and endemic diseases. The Company's RNA Targeting Pattern Toolkit, which includes RNA editing, splicing, antisense silencing and RNA interference (" RNAi "), provides the Company with a unique capability to design and sustainably deliver drug candidates that best address disease biology. The Company leads projects involving rare and prevalent diseases including α-1 antitrypsin deficiency (" AATD "), obesity, Duchenne muscular dystrophy (" DMD ") and Huntington's disease (" HD ").
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
